( NASDAQ-NMS:HZNP )

News from Grunenthal Group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 29, 2017, 09:44 ET Grünenthal Obtained a Red Dot Product Design Award for Its Innovative System for Post-Operative Pain Management

The Grünenthal Group, an R&D-driven, privately held international pharmaceutical company with headquarters in Aachen Germany, announced today...


May 23, 2017, 09:00 ET Cutting Edge Science in Pain Treatment in Order to Improve Patients' Lives - EFIC-GRÜNENTHAL GRANT 2016 Supports Six Young Scientists in Their Advanced Pain Research Projects

The European Pain Federation EFIC® in cooperation with the pharmaceutical company Grünenthal announced that six young research scientists in the...


Oct 04, 2016, 04:00 ET Gabriel Baertschi Takes Office as New CEO of Grünenthal Group as of October 1, 2016

The Grünenthal Group today announces that Gabriel Baertschi has taken office as new CEO of the Grünenthal Group, an independent,...


Sep 27, 2016, 05:40 ET A Research Consortium Under the Direction of Grünenthal Will Receive a Grant of €1.5 million From the European Fund for Regional Development and the Federal State of North Rhein-Westphalia

- Research grant awarded by Leitmarktwettbewerb LifeSciences.NRW to improve the development of new analgesic drugs  - The...


Oct 16, 2012, 10:30 ET INTAC® - Grunenthal Group presents data demonstrating the strength of its tamper resistant technology at the American Association of Pharmaceutical Science Annual Meeting and Exposition.

 Grunenthal, a global family-owned pharmaceutical company specializing in pain management, today announced that data will be presented in...


Sep 05, 2012, 15:30 ET Grunenthal To Present Data for its Innovative Formulation Technology INTAC® at PAINWeek 2012

Grunenthal, a global family-owned pharmaceutical company specializing in pain management, today announced the company's planned activities at this...


Jun 19, 2012, 10:02 ET Contrato exclusivo entre o Grupo Grünenthal e a Horizon Pharma para a comercialização do DUEXIS® na América Latina

O Grupo Grünenthal anunciou hoje a assinatura de um contrato de exclusividade para a comercialização do produto DUEXIS® na...


Jun 19, 2012, 10:00 ET Contrato exclusivo entre el Grupo Grünenthal y Horizon Pharma para la comercialización de DUEXIS® en América Latina

El Grupo Grünenthal anunció hoy la firma de un contrato de exclusividad con la empresa biofarmacéutica Horizon Pharma, Inc. (NASDAQ:...


Jun 19, 2012, 08:50 ET The Grünenthal Group Enters into Exclusive Agreement with Horizon Pharma for Commercialization of DUEXIS® in Latin America

The Grünenthal Group today announced that it has entered into an exclusive agreement with Horizon Pharma, Inc. (NASDAQ:  HZNP), a...